Carbavance
Carbavance is a fixed-dose combination of meropenem and vaborbactam, a beta-lactamase inhibitor. It is used in research to study treatments for complex urinary tract infections (cUTI) and pyelonephritis. This combination is investigated in vitro and in vivo for its efficacy against resistant Gram-negative bacterial pathogens.
Product Specifications
CAS Number
2031124-72-6
Field of Research
Infectious Disease & Virology
Smiles
C (O) (=O) C=1N2[C@@] ([C@@] ([C@@H] (C) O) (C2=O) [H]) ([C@@H] (C) C1S[C@H]3C[C@@H] (C (N (C) C) =O) NC3) [H].N (C (CC1=CC=CS1) =O) [C@@H]2B (O) O[C@H] (CC (O) =O) CC2
Molecular Formula
C29H41BN4O10S2
Molecular Weight
680.60
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-318952 500 mg
5-Nitro-2- (1-pyrrolidinyl) benzenecarboxylic acid
Sign In for Pricing
View Details 
